Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:EARS
Delisted

Auris Medical Holding AG Stock Price (Quote)

$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.680 $1.00 Friday, 27th May 2022 EARS stock ended at $0.750. This is 0.133% less than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 10.68% from a day low at $0.740 to a day high of $0.82.
90 days $0.635 $2.14
52 weeks $0.635 $4.58

Historical Auris Medical Holding AG prices

Date Open High Low Close Volume
Dec 12, 2016 $1.27 $1.34 $1.25 $1.26 105 160
Dec 09, 2016 $1.30 $1.30 $1.25 $1.29 89 188
Dec 08, 2016 $1.50 $1.50 $1.30 $1.31 340 409
Dec 07, 2016 $1.23 $1.45 $1.20 $1.45 494 262
Dec 06, 2016 $1.18 $1.22 $1.17 $1.20 123 965
Dec 05, 2016 $1.15 $1.19 $1.15 $1.16 100 752
Dec 02, 2016 $1.16 $1.21 $1.16 $1.16 48 845
Dec 01, 2016 $1.20 $1.21 $1.18 $1.20 48 616
Nov 30, 2016 $1.23 $1.23 $1.20 $1.20 67 616
Nov 29, 2016 $1.23 $1.24 $1.21 $1.23 135 698
Nov 28, 2016 $1.25 $1.25 $1.22 $1.23 58 742
Nov 25, 2016 $1.27 $1.27 $1.21 $1.24 11 243
Nov 23, 2016 $1.24 $1.24 $1.21 $1.21 48 784
Nov 22, 2016 $1.24 $1.28 $1.21 $1.24 99 845
Nov 21, 2016 $1.29 $1.29 $1.21 $1.24 112 449
Nov 18, 2016 $1.22 $1.22 $1.21 $1.21 66 956
Nov 17, 2016 $1.21 $1.22 $1.18 $1.22 89 317
Nov 16, 2016 $1.23 $1.24 $1.18 $1.22 136 308
Nov 15, 2016 $1.22 $1.25 $1.13 $1.22 239 596
Nov 14, 2016 $1.15 $1.21 $1.14 $1.20 303 240
Nov 11, 2016 $1.07 $1.14 $0.98 $1.12 341 351
Nov 10, 2016 $1.04 $1.06 $0.90 $1.04 332 896
Nov 09, 2016 $0.85 $1.00 $0.84 $0.97 152 680
Nov 08, 2016 $0.99 $1.05 $0.85 $0.92 262 033
Nov 07, 2016 $0.90 $0.99 $0.90 $0.98 167 900
Click to get the best stock tips daily for free!

About Auris Medical Holding AG

Auris Medical Holding AG Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has... EARS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT